Repligen CORP Form 4 insider transactions

Repligen CEO Olivier Loeillot disposed of 1,248 shares of common stock to cover tax obligations related to restricted stock units.

Repligen's Chief Financial Officer, Jason K. Garland, disposed of 412 shares of common stock to cover tax withholding obligations related to restricted stock units.

Repligen Corp Director Anthony Hunt exercised stock options and subsequently sold a portion of his common stock holdings as part of a pre-arranged 10b5-1 trading plan.

Repligen's Chief Accounting Officer, Violetta Hughes, received awards of 4,142 restricted stock units and 3,914 stock options.

Repligen CEO Olivier Loeillot disposed of 2,506 shares of common stock to cover tax obligations related to restricted stock units.

Repligen Corporation Director Martin D. Madaus acquired 1,800 shares of common stock at an average price of $112.128 through a pre-arranged trading plan.

Director Nicolas Barthelemy reports the acquisition of restricted stock units and stock options in Repligen Corp.

Konstantin Konstantinov, a director at Repligen Corp, reported the acquisition of stock options and restricted stock units in a recent SEC filing.

Director Glenn P. Muir reports acquisition of 973 restricted stock units and 1,800 stock options in Repligen Corp.

Carrie Eglinton Manner, a director at Repligen Corp, reported the acquisition of restricted stock units and stock options.

Director Karen A. Dawes reports acquisition of restricted stock units and stock options in Repligen Corporation.

Director Martin D. Madaus reports the acquisition of restricted stock units and stock options in Repligen Corporation.

Director Margaret Pax reports the acquisition of restricted stock units and stock options in Repligen Corporation.

Director Rohin Mhatre reports the acquisition of restricted stock units and stock options in Repligen Corporation.

Director Anthony Hunt of Repligen Corp sold a significant number of shares on May 15, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Operating Officer James Bylund reports a transaction involving Repligen Corp common stock to cover tax obligations.

James Bylund, Chief Operating Officer of Repligen Corp, reports acquisition and disposal of common stock related to performance stock units.

Director Anthony Hunt of Repligen Corp reports exercising stock options and selling shares under a pre-arranged 10b5-1 trading plan.

Director Margaret Pax reported a transaction involving Repligen Corp (RGEN) common stock on March 17, 2025.

Repligen's CFO, Jason K. Garland, reports the acquisition of restricted stock units and stock options, as well as the disposal of common stock.

Senior VP of R&D at Repligen Corp, Ralf Kuriyel, reports acquisition of restricted stock units and stock options, along with a disposition of shares to cover tax obligations.

Director Anthony Hunt disposed of 10,142 shares of Repligen Corp to cover tax obligations arising from the release of restricted stock units.

James Bylund, Chief Operating Officer of Repligen Corp, reports acquisition of restricted stock units and stock options, as well as disposition of shares to cover tax obligations.

Repligen's CEO, Olivier Loeillot, reports the acquisition of restricted stock units and stock options, according to a Form 4 filing with the SEC.

Repligen CFO Jason K. Garland disposed of 316 shares of common stock on February 27, 2025, to cover tax withholding obligations.

Repligen's CEO, Olivier Loeillot, disposed of 343 shares of common stock on February 27, 2025, to cover tax withholding obligations related to the release of performance stock units.

Chief Operating Officer James Bylund of Repligen Corp reports disposition of shares to cover tax obligations arising from released performance stock units.

Ralf Kuriyel, Senior VP of R&D at Repligen Corp, disposed of 391 shares of common stock on February 27, 2025, to cover tax withholding obligations.

Director Anthony Hunt of Repligen Corp. reports disposition of shares to cover tax obligations arising from the release of performance stock units.

Senior VP of R&D at Repligen Corp, Ralf Kuriyel, disposed of 275 shares to cover tax obligations arising from the release of performance stock units.